Citigroup
VAXX

Citigroup’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Citigroup’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,101
Closed -$5.09K – 5857
2024
Q1 		$5.09K Buy
7,101
+1,033
+17% +$749 ﹤0.01% 5322
2023
Q4 		$5.16K Buy
6,068
+6,046
+27,482% +$5.84K ﹤0.01% 5329
2023
Q3 		$30 Sell
22
-12,671
-100% -$27.5K ﹤0.01% 5565
2023
Q2 		$32K Buy
+12,693
New +$26.9K ﹤0.01% 4835
2022
Q3 		– Sell
-1,447
Closed -$2K – 6468
2022
Q2 		$2K Buy
+1,447
New +$5.47K ﹤0.01% 5942

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Citigroup's VAXX Position: Q2 2024 in Review

Citigroup sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 7,101 shares — an estimated $5.09K sold.

Citigroup first reported a position in VAXX in Q2 2022 and held it in 5 quarters. The position peaked at $32K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Citigroup reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Citigroup sold 7,101 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $5.09K.
  • Citigroup first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2022 and held it in 5 quarters.
  • Citigroup's Vaxxinity, Inc. Class A Common Stock position peaked at $32K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.